ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Accounts receivable, net

Alfresa Holdings Corporation (2784)

Market cap
¥472.7B
P/E ratio
12.5x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 2021592,321-0.51%
Mar 31, 2020595,353-3.05%
Mar 31, 2019614,084+0.19%
Mar 31, 2018612,920+1.82%
Mar 31, 2017601,962-1.67%
Mar 31, 2016612,182+2.41%
Mar 31, 2015597,779

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat